Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Genetic findings confirm vitamin D–MS link

01 September 2015

By Lubna Ahmed

Appeared in BioNews 817

A study by researchers in Canada has found that people who are genetically susceptible to low vitamin-D levels are at a higher risk of multiple sclerosis (MS).

The findings of the large study, published in PLoS Medicine, support the theory that there is a link between low levels of vitamin D and MS.

In the study, the researchers examined the DNA of nearly 34,000 participants of European descent and identified four SNPs (single nucleotide polymorphisms) linked with significantly lower levels of a vitamin D blood marker.

When comparing people with MS and the healthy controls, the researchers found that those who possessed fewer of these SNPs, and were therefore prone to vitamin D deficiency, were twice as likely to have MS.

Previous observational studies have suggested an association between a lack of vitamin D and MS, but this is the first genetic correlation to be found.

The authors, led by Dr Brent Richards from McGill University, wrote: 'The identification of vitamin D as a causal susceptibility factor for MS may have important public health implications, since vitamin D insufficiency is common, and vitamin D supplementation is both relatively safe and cost-effective.'

MS is an autoimmune disease that damages nerves and spinal cord, causing problems in vision, balance and movement. A link between the disease and vitamin D has been posited for a while, as the incidence has been consistently shown to increase with latitude, and therefore decreasing sun exposure.

Vitamin D can be obtained through exposure to sunlight, as well as through diet in foods like eggs, oily fish or fortified foods such as cereal.

'In many of the other examples tried, the notion that all will be well if we simply give patients a large dose of vitamin D supplements has proved too simple,' commented Professor Danny Altmann from Imperial College London.

'However, vitamin D is relatively cheap, safe and many of us would be all the healthier if we could achieve the serum levels that our ancient ancestors presumably acquired when roaming outdoors in temperate climates, unclothed and eating a diverse diet including oily fish.'

Clinical trials are ongoing to assess vitamin D supplementation as a treatment method or preventative measure for MS.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

11 September 2017 - by Annabel Slater 
Mice deprived of two essential fatty acids during pregnancy give birth to pups with schizophrenia-like symptoms...
06 June 2016 - by Dr Lucy Freem 
A gene variant has been linked to early onset multiple sclerosis in a small number of cases, lending weight to the hypothesis that genetic factors underlie multiple sclerosis more widely...
25 January 2016 - by Dr Lanay Griessner 
A stem cell treatment routinely used for bone and blood cancers is showing promise at reversing the effects of multiple sclerosis...

26 January 2015 - by Dr Tamara Hirsch 
An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis has demonstrated neurological improvement and enhanced quality of life for patients...
23 July 2012 - by Holly Rogers 
A genetic variation could explain why a previously promising class of drugs do not work as multiple sclerosis treatments despite being used successfully in other autoimmune diseases...
12 December 2011 - by Owen Clark 
A rare genetic variant causing lower levels of vitamin D has been linked to multiple sclerosis (MS), according to scientists...
06 June 2011 - by Mehmet Fidanboylu 
Researchers have found a link between genetics and the environment that may help to explain the development of multiple sclerosis (MS). The study, published in Nature Communications, identified how vitamin D obtained through diet or sunlight, interacts with certain genes...
04 May 2010 - by Dr Gabrielle Samuel 
Environmental factors, rather than genetics, may play a key role in multiple sclerosis (MS), according to new research published in Nature...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation